Search Tag: personalised and precision medicine

IT Management

2015 10 Aug

The U.S. Food and Drug Administration has approved the first 3D-printed drug, SPRITAM ® , for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalised tonic-clonic seizures in adults and children with epilepsy.   The FDA approval is being hailed as a breakthrough in precision...Read more